« Previous
Next »
Urology
Volume 79, Issue 5
, Pages 996-1003
, May 2012
Factors Influencing Urologist Treatment Preference in Surgical Management of Stone Disease
To access this article, please choose from the options below
Financial Disclosure: J. E. Lingeman is a consultant/adviser, meeting participant/lecturer for Lumenis, consultant/adviser, investor, meeting participant/lecturer, scientific study/trial investigator for Boston Scientific, consultant/adviser for Olympus, meeting participant/lecturer for Karl Storz Medical, owner, medical director of Beck Analytic, owner of and investor in Midwest Mobile Lithotripsy, and owner of and investor in Midstate Mobile Lithotriptor.
Funding Support: This study was supported by the Department of Urology, Mayo Clinic, Rochester, Minnesota.
PII: S0090-4295(11)02659-8
doi: 10.1016/j.urology.2011.11.024
© 2012 Elsevier Inc. All rights reserved.
« Previous
Next »
Urology
Volume 79, Issue 5
, Pages 996-1003
, May 2012
